VolitionRx Limited Awarded an Additional $4 Million in Non-Dilutive Funding
VolitionRx Limited Appoints Dr. Tom Butera DVM to Board of Directors
Volition Launches Nu.Q™ Vet Cancer Screening Test in the U.S.
VolitionRx Limited to Present COVID-19 Data at MEDICA 2020
VolitionRx Limited Announces Third Quarter 2020 Financial Results and Business Update
Volition Veterinary Presents Expert Report Ahead of First Product Launch
VolitionRx Limited Schedules Third Quarter 2020 Earnings Conference Call and Business Update
VolitionRx Limited Releases Video of Virtual Capital Markets Day 2020
VolitionRx Limited Announces Details for Virtual Capital Markets Day 2020
Volition Veterinary Diagnostics Development LLC Announces Product Data Regarding its Nu.Q™ Vet Cancer Screening Test in Lymphoma and Hemangiosarcoma to be Presented at the 2020 VCS Virtual Annual Conference